Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Treatments for immune thrombocytopenic purpura (ITP) providing durable platelet responses without continued dosing are limited. Whereas complete responses (CRs) to B-cell depletion in ITP usually last for 1 year in adults, partial responses (PRs) are less durable. Comparable data do not exist for ch...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Patel, Vivek L., Mahévas, Matthieu, Lee, Soo Y., Stasi, Roberto, Cunningham-Rundles, Susanna, Godeau, Bertrand, Kanter, Julie, Neufeld, Ellis, Taube, Tillmann, Ramenghi, Ugo, Shenoy, Shalini, Ward, Mary J., Mihatov, Nino, Patel, Vinay L., Bierling, Philippe, Lesser, Martin, Cooper, Nichola, Bussel, James B.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2012
Assuntos:
Clinical Trials and Observations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383014/
https://ncbi.nlm.nih.gov/pubmed/22566601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-11-393975
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares